IDW Media Holdings, Inc. (OTCQB:IDWM) reported its financial results for the third quarter ended July 31, 2026. The company will host a conference call on September 14, 2026, at 4:30 PM Eastern time for a Q&A session regarding these results. IDW is an integrated media company focused on developing intellectual property across comics, graphic novels, television, and other entertainment platforms.

Northrop Grumman Systems Corp. has secured two U.S. defense contracts totaling approximately $38.7 million. One contract, valued at nearly $20 million, is for the procurement of non-standard ammunition by its Radford, Virginia division. The second contract, an $18.7 million modification, tasks its Oklahoma City division with manufacturing B-2 hot trailing edges.

The BIGY ETF, or Evolve US Equity UltraYield ETF Trust Units -Hedged-, primarily invests in US equities with a strategy to enhance yield and reduce volatility through covered call writing and leverage. The fund was incepted on September 9, 2025, and manages its currency exposure through hedged and unhedged units. It also engages in securities lending for additional income, with current assets under management at 358.53 million CAD and a dividend yield of 42.28%.

This article examines how Rockwell Automation (NYSE:ROK) is navigating a challenging macro environment characterized by rising costs, firm Treasury yields, and inflation concerns. It highlights the importance of company-specific execution in addressing increased operating expenses and maintaining demand momentum, especially given the company's direct ties to capital spending, aerospace and defense demand, automation trends, and supply-chain execution. The piece emphasizes that market attention is currently focused on how businesses like Rockwell Automation absorb higher costs without losing demand, making operational clarity and disciplined resource deployment critical.

Public Service Enterprise Group (NYSE:PEG) CEO Ralph A. LaRossa sold 2,083 shares of the company stock for $153,000 on September 1, 2026. This transaction represents 0.7% of his direct holdings, and he still retains over 281,000 shares. Despite the stock's 11.7% decline over the past year, analysts have a mixed outlook, with a median one-year price target suggesting an 18.8% gain.

Fitch Ratings has upgraded Citizens Financial Group and its subsidiary Citizens Bank to 'A-' from 'BBB+', citing consistent improvements in earnings power and profitability. The upgrade reflects sustained margin expansion, stable credit costs, and growth in fee-generating businesses like private banking and capital markets. This move aligns Citizens Financial's credit profile with its large regional peers, recognizing its strong market presence and diverse revenue streams.

J.P. Morgan provided a $7.5 million New Markets Tax Credit (NMTC) equity investment to support the Sankofa Village Wellness Center in Chicago's West Garfield Park, an underserved community. This center, opened in 2026, aims to expand access to quality healthcare and other vital services like fitness and employment assistance, addressing a significant disparity in life expectancy and health outcomes. The NMTC investment also facilitates future community ownership of the facility, empowering local residents.

A Livonia homeowner, Dave Pietrowski, finally received a resolution from DTE Energy months after storm damage left his yard in disarray and a utility pole leaning precariously. After repeated unsuccessful attempts to get the issue fixed, Pietrowski contacted 7 News Detroit, which prompted DTE to dispatch crews to complete the repairs and landscaping. DTE apologized for the delay and urged customers to contact them with concerns.

Energy Transfer (ET) is delisting its common and Series I preferred units from the New York Stock Exchange, with trading ceasing on October 2, 2026. The company will transition its trading to the Texas Stock Exchange starting October 5, 2026, under the same tickers. This strategic move aims to align the Texas-based energy operator with TXSE's technology-driven platform.

Novo Nordisk's stock dropped over 2% after Morgan Stanley downgraded its rating due to long-term risks associated with its drug semaglutide. The brokerage expects semaglutide to comprise about 75% of Novo's sales by 2026, making the company vulnerable to loss of exclusivity starting in 2031 and potential generic competition. Morgan Stanley also noted weaker momentum in U.S. prescriptions for Wegovy and increased competition from Eli Lilly's Zepbound.